GlassScriptPhysician profile
Ralph Maroun
NPI 1982157608
$4,431.16
in general payments reported to CMS, 2019-2025
30 companies · $1,705 in 2025
The $1,705 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $149 · 2021: $335 · 2022: $291 · 2023: $973 · 2024: $840 · 2025: $1,705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,452 · Education: $64.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,452.46 |
| Education | $64.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $775.92 | 2023-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Amgen INC. | $525.60 | 2023-2025 | Tezspire, Tavneos |
| Insmed, INC. | $523.09 | 2019-2025 | Arikayce, Brinsupri |
| Astrazeneca Pharmaceuticals LP | $401.78 | 2019-2025 | Tezspire, Airsupra, Breztri |
| Grifols USA, LLC | $283.24 | 2021-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $276.84 | 2021-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Regeneron Healthcare Solutions, INC. | $210.85 | 2024-2025 | Dupixent |
| Baxter Healthcare | $190.54 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Abbvie INC. | $168.12 | 2021-2024 | |
| Actelion Pharmaceuticals US, INC. | $160.68 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Philips North America LLC | $126.90 | 2022-2025 | Vest Therapy Und |
| Electromed, INC. | $125.10 | 2024-2025 | Smartvest |
| La Jolla Pharmaceutical Company | $75.57 | 2025 | Giapreza |
| Takeda Pharmaceuticals U.S.A., INC. | $73.51 | 2024-2025 | Glassia |
| Ani Pharmaceuticals, INC. | $72.21 | 2023-2024 | Purified Cortrophin Gel |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $68.41 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $48.89 | 2019-2021 | |
| Viatris Specialty LLC | $44.66 | 2025 | Yupelri |
| Mylan Specialty L.P. | $41.88 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $33.98 | 2021 | |
| Merck Sharp & Dohme LLC | $31.04 | 2025 | Keytruda |
| Mallinckrodt Hospital Products INC. | $29.55 | 2025 | Acthar |
| Inogen, INC. | $22.37 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Circassia INC. | $19.86 | 2019 | |
| Verona Pharma, INC. | $18.98 | 2025 | Ohtuvayre |
| Genentech USA, INC. | $17.90 | 2020 | |
| Shionogi INC | $17.28 | 2022 | |
| Gilead Sciences, INC. | $16.62 | 2023 | Veklury |
| Alexion Pharmaceuticals, INC. | $15.23 | 2021 | |
| Pulmonx Corporation | $14.56 | 2023 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Maroun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.